IC
MYOV

Ikarian Capital’s Myovant Sciences Ltd. MYOV Stock Holding History

Ikarian Capital’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-25,999
Closed -$484K – 225
2020
Q2 		$536K Sell
25,999
-424,001
-94% -$5.77M 0.04% 132
2020
Q1 		$3.4M Buy
+450,000
New +$5.05M 0.26% 77

Other funds holding MYOV

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $606M AUM 63.41% 1-Year Est. Return

Ikarian Capital's MYOV Position: Q3 2020 in Review

Ikarian Capital sold out of Myovant Sciences Ltd. (MYOV) in Q3 2020, closing a stake of 25,999 shares — an estimated $484K sold.

Ikarian Capital first reported a position in MYOV in Q1 2020 and held it in 2 quarters. The position peaked at $3.4M in Q1 2020. 102 funds tracked by Wall St. Rank hold MYOV as of Q3 2020.

  • Ikarian Capital reported no remaining Myovant Sciences Ltd. position as of Q3 2020 after selling out during the quarter.
  • Ikarian Capital sold 25,999 Myovant Sciences Ltd. shares in Q3 2020, an estimated $484K.
  • Ikarian Capital first reported a position in Myovant Sciences Ltd. in Q1 2020 and held it in 2 quarters.
  • Ikarian Capital's Myovant Sciences Ltd. position peaked at $3.4M in Q1 2020.
  • 102 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q3 2020.

Based on Ikarian Capital's 13F filing for Q3 2020, filed 16 Nov 2020.